Autoimmune Polyendocrine Syndrome Type II

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Autoimmune Polyendocrine Syndrome Type II trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05578105

Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

Autoimmune polyendocrine syndrome (APS) is an autoimmune disease involving at least two endocrine organ. It is classified into type I and type II diseases. Amon…

Taiwan650 participantsStarted 2022-01-01

Treatment: no intervention

Autoimmune Polyendocrine Syndrome Type II

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

All recent trials (1 shown)